ÂÜÀòÂÒÂ×

The Research and Development Team at Cytodel, Inc. focuses on innovating and refining recombinant derivatives of botulinum neurotoxin through cutting-edge molecular biology techniques. This team, comprised of researchers and medical consultants, collaborates to advance the efficacy and safety of biopharmaceutical products, driving the company’s commitment to breakthrough therapies in neurology and aesthetic medicine.